Trends in Passive IoT Biomarker Monitoring and Machine Learning for Cardiovascular Disease Management in the U.S. Elderly Population-Advances in Geriatric Medicine and Research-CSCIED科技核心评价数据库-手机版

Trends in Passive IoT Biomarker Monitoring and Machine Learning for Cardiovascular Disease Management in the U.S. Elderly Population

Trends in Passive IoT Biomarker Monitoring and Machine Learning for Cardiovascular Disease Management in the U.S. Elderly Population

ES评分 0 浏览量：634 下载量：1

全文阅读下载引用收藏

DOI	10.20900/agmr20230002
刊名	Advances in Geriatric Medicine and Research AGMR
年，卷(期)	2023, 5(1)
作者	Brian F. Bender*,Jasmine A. Berry,
作者单位	1 Intake Health Inc., Raleigh, NC 27601, USA; 2 Robotics Institute, University of Michigan, College of Engineering, Ann Arbor, MI 48109, USA
Abstract	It is predicted that the growth in the U.S. elderly population alongside continued growth in chronic disease prevalence will further strain an already overburdened healthcare system and could compromise the delivery of equitable care. Current trends in technology are demonstrating successful application of artificial intelligence (AI) and machine learning (ML) to biomarkers of cardiovascular disease (CVD) using longitudinal data collected passively from internet-of-things (IoT) platforms deployed among the elderly population. These systems are growing in sophistication and deployed across evermore use-cases, presenting new opportunities and challenges for innovators and caregivers alike. IoT sensor development that incorporates greater levels of passivity will increase the likelihood of continued growth in device adoption among the geriatric population for longitudinal health data collection which will benefit a variety of CVD applications. This growth in IoT sensor development and longitudinal data acquisition is paralleled by the growth in ML approaches that continue to provide promising avenues for better geriatric care through higher personalization, more real-time feedback, and prognostic insights that may help prevent downstream complications and relieve strain on the healthcare system overall. However, findings that identify differences in longitudinal biomarker interpretations between elderly populations and relatively younger populations highlights the necessity that ML approaches that use data from newly developed passive IoT systems should collect more data on this target population and more clinical trials will help elucidate the extent of benefits and risks from these data driven approaches to remote care.
KeyWord	Internet of things (IoT); geriatric; cardiovascular diseases; machine learning; passive monitoring; artificial intelligence; hypertension; heart failure; CVD; remote care
基金项目
页码	-

参考文献
相关文献

1. Mohebi R, Chen C, Ibrahim N, McCarthy CP, Gaggin HK, Singer DE, et al. Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates. J Am Coll Cardiol. 2022;80(6):565-78. 2. Vespa J, Medina L, Armstrong DM. Demographic Turning Points for the United States: Population Projections for 2020 to 2060. Washington, (DC, US): U.S. Census Bureau; 2020. p. 25-1144. 3. Prince MJ, Wu F, Guo Y, Robledo LM, O’Donnell M, Sullivan R, Yusuf S. The burden of disease in older people and implications for health policy and practice. Lancet. 2015;385(9967):549-62. doi: 10.1016/S0140-6736(14)61347-7 4. Fulmer T, Reuben DB, Auerbach J, Fick DM, Galambos C, Johnson KS. Actualizing Better Health And Health Care For Older Adults: Commentary describes six vital directions to improve the care and quality of life for all older Americans. Health Affairs. 2021;40(2):219-25. doi: 10.1377/hlthaff.2020.01470 5. Kelly JT, Campbell KL, Gong E, Scuffham P. The Internet of Things: Impact and Implications for Health Care Delivery. J Med Internet Res. 2020;22(11):e20135. doi: 10.2196/20135. 6. Brick TR, Mundie J, Weaver J, Fraleigh R, Oravecz Z. Low-Burden Mobile Monitoring, Intervention, and Real-Time Analysis Using the Wear-IT Framework: Example and Usability Study. JMIR Form Res. 2020;4(6):e16072. doi: 10.2196/16072 7. Alwan M. Passive in-home health and wellness monitoring: overview, value and examples. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:4307-10. doi: 10.1109/IEMBS.2009.5333799 8. Knowles M, Krasniansky A, Nagappan A, Zweig M, Somaiya M, Consumer adoption of digital health in 2022: Moving at the speed of trust, Rock Health. 2023. Available from: https://rockhealth.com/insights/consumer-adoption-of-digital-health-in-2022-moving-at-the-speed-of-trust/. Accessed 2023 Mar 30. 9. Powers R, Etezadi-Amoli M, Arnold EM, Kianian S, Mance I, Gibiansky M, et al. Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson’s disease. Sci. Transl. Med. 2021;13:eabd7865. 10. Whoop, WHOOP Identifies Novel Pregnancy Digital Biomarker to Screen for Premature Birth, (2022). Available from: https://www.whoop.com/thelocker/whoop-identifies-novel-pregnancy-digital-biomarker-to-screen-for-premature-birth/#:~:text=The WHOOP Inflection Point is,as HRV began to rebound. Accessed 2023 Mar 30. 11. Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017-2018, NCHS Data Brief. 2020 Apr;(364):1-8. 12. deFilippi CR, Christenson RH, Gottdiener JS, Kop WJ, Seliger SL. Dynamic Cardiovascular Risk Assessment in Elderly People: The Role of Repeated N-Terminal Pro–B-Type Natriuretic Peptide Testing. J Am Coll Cardiol. 2010;55:441-50. 13. Sedighi SM, Prud’Homme P, Ghachem A, Lepage S, Nguyen M, Fulop T, et al. Increased level of high-sensitivity cardiac Troponin T in a geriatric population is determined by comorbidities compared to age. IJC Hear Vasc. 2019;22:187–91. 14. Bargieł W, Cierpiszewska K, Maruszczak K, Pakuła A, Szwankowska D, Wrzesińska A, et al. Recognized and potentially new biomarkers—their role in diagnosis and prognosis of cardiovascular disease, Medicina (Kaunas). 2021;57:1–30. 15. Sung K, Ryu S, Lee J, Lee SH, Cheong E, Hyun Y-Y, et al. Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality. J Am Heart Assoc. 2016;5(9):e003245. doi: 10.1161/JAHA.116.003245 16. Ma Y, He FJ, Sun Q, Yuan C, Kieneker LM, Curhan GC, et al. 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk. N Engl J Med. 2022;386(3):252-263. doi: 10.1056/NEJMoa2109794 17. Madero M, Sarnak MJ. Association of cystatin C with adverse outcomes. Curr Opin Nephrol Hypertens. 2009;18(3):258-63. 18. Angoff R, Mosarla RC, Tsao CW. Aortic stiffness: Epidemiology, risk factors, and relevant biomarkers. Front Cardiovasc Med. 2021;8:1–15. 19. Baig M, Moafi-Madani M, Qureshi R, Roberts MB, Allison M, Manson JA, et al. Heart rate variability and the risk of heart failure and its subtypes in post-menopausal women: The Women’s Health Initiative study, PLoS One. 2022;17:1–16. 20. Aydemir VB, Nagesh S, Shandhi MMH, Fan J, Klein L, Etemadi M, et al. Classification of Decompensated Heart Failure From Clinical and Home Ballistocardiography. IEEE Trans Biomed Eng. 2020;67:1303–13. 21. Homhuan W, Poomthavorn P, Paksi W, Khlairit P, Nongnuch A, Pirojsakul K. Masked hypertension and its associations with glycemic variability metrics in children and adolescents with type 1 diabetes. Pediatr Nephrol. 2021;36(2):379-86. doi: 10.1007/s00467-020-04720-2 22. Sezer H, Yazici D, Copur S, Dagel T, Deyneli O, Kanbay M. The relationship between glycemic variability and blood pressure variability in normoglycemic normotensive individuals. Blood Press Monit. 2021;26(2):102-7. doi: 10.1097/MBP.0000000000000491 23. Baig MM, Afifi S, GholamHosseini H, Mirza F. A Systematic Review of Wearable Sensors and IoT-Based Monitoring Applications for Older Adults – a Focus on Ageing Population and Independent Living. J Med Syst. 2019;43:233. 24. Huang JD, Wang J, Ramsey E, Leavey G, Chico TJA, Condell J. Applying Artificial Intelligence to Wearable Sensor Data to Diagnose and Predict Cardiovascular Disease: A Review. Sensors. 2022;22:1-28. 25. Winokur ES, He DD, Sodini CG. A wearable vital signs monitor at the ear for continuous heart rate and Pulse Transit Time measurements, in: 2012. Annu Int Conf IEEE Eng Med Biol Soc. 2012:2724–2727. 26. Charlton PH, Kyriacou PA, Mant J, Marozas V, Chowienczyk P, Alastruey J. Wearable Photoplethysmography for Cardiovascular Monitoring. Proc IEEE. 2022;110:355-81. 27. Sadek I, Biswas J, Abdulrazak B. Ballistocardiogram signal processing: a review. Health Inf Sci Syst. 2019;7(1):10. doi: 10.1007/s13755-019-0071-7 28. Cruz BDP, Ahmadi M, Inan-Eroglu E, Huang BH, Stamatakis E. Prospective Associations of Accelerometer-Assessed Physical Activity With Mortality and Incidence of Cardiovascular Disease Among Adults With Hypertension: The UK Biobank Study, J. Am. Heart Assoc. 2022;11:1–12. 29. Miller KM, Hermann J, Foster N, Hofer SE, Rickels MR, Danne T, et al. Longitudinal changes in continuous glucose monitoring use among individuals with type 1 Diabetes: International comparison in the German and Austrian DPV and U.S. T1D exchange registries. Diabetes Care. 2020;43:E1-2. 30. Wakasugi S, Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, et al. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes. Cardiovasc Diabetol. 2021;20:1–12. 31. Martinez M, Santamarina J, Pavesi A, Musso C, Umpierrez GE. Glycemic variability and cardiovascular disease in patients with type 2 diabetes. BMJ Open Diabetes Res. Care. 2021;9:1–7. 32. Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12:288-98. 33. Singh A, Sharma A, Ahmed A, Sundramoorthy AK, Furukawa H, Arya S, et al. Recent advances in electrochemical biosensors: Applications, challenges, and future scope, Biosensors. 2021;11:1–31. 34. Düking P, Giessing L, Frenkel MO, Koehler K, Holmberg H-C, Sperlich B. Wrist-Worn Wearables for Monitoring Heart Rate and Energy Expenditure While Sitting or Performing Light-to-Vigorous Physical Activity: Validation Study, JMIR Mhealth Uhealth. 2020;8:e16716. 35. Khurshid Weng SLC, Nauffal V, Pirruccello JP, Venn RA, Al-Alusi MA, et al. Wearable accelerometer-derived physical activity and incident disease. NPJ Digit Med. 2022;5:1–10. 36. Gupta N, Yang J, Reynolds K, Lenane J, Garcia E, Sung SH, et al. Diagnostic Yield, Outcomes, and Resource Utilization With Different Ambulatory Electrocardiographic Monitoring Strategies. Am J Cardiol. 2022;166:38-44. doi: 10.1016/j.amjcard.2021.11.027 37. Ding EY, CastañedaAvila M, Van Tran K, Mehawej J, Filippaios A, Paul T, et al. Usability of a smartwatch for atrial fibrillation detection in older adults after stroke. Cardiovasc Digit Heal J. 2022;3:126–35. 38. de Andrade PE, do Amaral JAT, da S. Paiva L, Adami F, Raimudo JZ, Valenti VE, et al. Reduction of heart rate variability in hypertensive elderly. Blood Press. 2017;26:350-8. 39. Kang J, Chang Y, Kim Y, Shin H, Ryu S. Ten-Second Heart Rate Variability, Its Changes Over Time, and the Development of Hypertension, Hypertension. 2022;79:1308–18. 40. Scholten HJ, Shih CD, Ma R, Malhotra K, Reyzelman AM. Utilization of a Smart Sock for the Remote Monitoring of Patients With Peripheral Neuropathy: Cross-sectional Study of a Real-world Registry. JMIR Form. Res. 2022;6:1-7. 41. Yavuz M, Ersen A, Monga A, Lavery LA, Garrett AG, Salem Y, et al. Temperature- and Pressure-Regulating Insoles for Prevention of Diabetic Foot Ulcers. J Foot Ankle Surg. 2020;59(4):685-8. doi: 10.1053/j.jfas.2019.05.009 42. Wang D, Ouyang J, Zhou P, Yan J, Shu L, Xu X. A Novel Low-Cost Wireless Footwear System for Monitoring Diabetic Foot Patients. IEEE Trans Biomed Circuits Syst. 2021;15(1):43-54. doi: 10.1109/TBCAS.2020.3043538 43. Prieto-Avalos G, Cruz-Ramos NA, Alor-Hernández G, Sánchez-Cervantes JL, Rodríguez-Mazahua L, Guarneros-Nolasco LR, et al. Wearable Devices for Physical Monitoring of Heart: A Review. Biosensors. 2022;12:1–31. 44. Seok W, Lee KJ, Cho D, Roh J, Kim S. Blood Pressure Monitoring System Using a Two-Channel Ballistocardiogram and Convolutional Neural Networks. Sensors (Basel). 2021;21(7):2303. doi: 10.3390/s21072303 45. Chen Y, Kaneko M, Hirose S, Chen W. Real-time Respiration Measurement during Sleep Using a Microwave Sensor. Annu Int Conf IEEE Eng Med Biol Soc. 2019;2019:3791-4. doi: 10.1109/EMBC.2019.8856589 46. Gleichauf J, Herrmann S, Hennemann L, Krauss H, Nitschke J, Renner P, et al. Automated Non-Contact Respiratory Rate Monitoring of Neonates Based on Synchronous Evaluation of a 3D Time-of-Flight Camera and a Microwave Interferometric Radar Sensor. Sensors (Basel). 2021;21(9):2959. doi: 10.3390/s21092959 47. Guerrero G, Kortelainen JM, Palacios E, Bianchi AM, Tachino G, Tenhunen M, et al. Detection of sleep-disordered breating with Pressure Bed Sensor. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:1342-5. doi: 10.1109/EMBC.2013.6609757 48. Huysmans D, Borzée P, Testelmans D, Buyse B, Willemen T, Huffel SV, et al. Evaluation of a Commercial Ballistocardiography Sensor for Sleep Apnea Screening and Sleep Monitoring. Sensors (Basel). 2019;19(9):2133. doi: 10.3390/s19092133 49. Sadek I, Heng TTS, Seet E, Abdulrazak B. A New Approach for Detecting Sleep Apnea Using a Contactless Bed Sensor: Comparison Study. J Med Internet Res. 2020;22(9):e18297. doi: 10.2196/18297 50. Despins LA, Guidoboni G, Skubic M, Sala L, Enayati M, Popescu M, et al. Using Sensor Signals in the Early Detection of Heart Failure: A Case Study. J Gerontol Nurs. 2020;46(7):41-6. doi: 10.3928/00989134-20200605-07 51. Tanaka S, Nogawa M, Yamakoshi K. Fully automatic system for monitoring blood pressure from a toilet-seat using the volume-oscillometric method. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:3939-41. doi: 10.1109/IEMBS.2005.1615323 52. Conn NJ, Schwarz KQ, Borkholder DA. In-Home Cardiovascular Monitoring System for Heart Failure: Comparative Study. JMIR Mhealth Uhealth. 2019 Jan 18;7(1):e12419. doi: 10.2196/12419 53. Bender BF, Johnson NJ, Berry JA, Frazier KM, Bender MB. Automated Urinal-Based Specific Gravity Measurement Device for Real-Time Hydration Monitoring in Male Athletes. Front. Sports Act. Living 2022;4:921418. doi: 10.3389/fspor.2022.921418 54. Martens P, Dupont M, Verbrugge FH, Damman K, Degryse N, Nijst P, et al. Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure. JACC Heart Fail. 2019 May;7(5):404-14. doi: 10.1016/j.jchf.2019.02.011 55. Damman K, Ter Maaten JM, Coster JE, Krikken JA, van Deursen VM, Krijnen HK, et al. Clinical importance of urinary sodium excretion in acute heart failure. Eur J Heart Fail. 2020 Aug;22(8):1438-47. doi: 10.1002/ejhf.1753 56. Kholghi M, Szollosi I, Hollamby M, Bradford D, Zhang Q. A validation study of a ballistocardiograph sleep tracker against polysomnography. J Clin Sleep Med. 2022;18(4):1203-10. doi: 10.5664/jcsm.9754. 57. Zhang L, Hurley NC, Ibrahim B, Spatz E, Krumholz HM, Jafari R, et al. Developing Personalized Models of Blood Pressure Estimation from Wearable Sensors Data Using Minimally-trained Domain Adversarial Neural Networks. Proc Mach Learn Res. 2020;126:97-120. 58. Rashid J, Batool S, Kim J, Wasif Nisar M, Hussain A, Juneja S, et al. An Augmented Artificial Intelligence Approach for Chronic Diseases Prediction. Front Public Health. 2022;10:860396. doi: 10.3389/fpubh.2022.860396 59. Shamanna P, Dharmalingam M, Sahay R, Mohammed J, Mohamed M, Poon T, et al. Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program. Sci Rep. 2021;11(1):14892. doi: 10.1038/s41598-021-94339-6 60. Mena LJ, Félix VG, Ochoa A, Ostos R, González E, Aspuru J, et al. Mobile Personal Health Monitoring for Automated Classification of Electrocardiogram Signals in Elderly. Comput Math Methods Med. 2018;2018:9128054. doi: 10.1155/2018/9128054 61. Omboni S. Connected Health in Hypertension Management. Front Cardiovasc Med. 2019;6:76. doi: 10.3389/fcvm.2019.00076 62. Desai F, Chowdhury D, Kaur R, Peeters M, Arya RC, Wander GS, et al. HealthCloud: A system for monitoring health status of heart patients using machine learning and cloud computing. Internet Things. 2022;17:100485. 63. Lear SA, Araki Y, Maric B, Kaan A, Horvat D. Prevalence and characteristics of home Internet access in patients with cardiovascular disease from diverse geographical locations. Can J Cardiol. 2009;25(10):589-93. 64. Indraratna P, Tardo D, Yu J, Delbaere K, Brodie M, Lovell N, et al. Mobile phone technologies in the management of ischemic heart disease, heart failure, and hypertension: systematic review and meta-analysis. JMIR mHealth and uHealth. 2020;8(7):e16695. 65. Raju KB, Dara S, Vidyarthi A, Gupta VM, Khan B. Smart Heart Disease Prediction System with IoT and Fog Computing Sectors Enabled by Cascaded Deep Learning Model. Comput Intell Neurosci. 2022 Jan 10;2022:1070697. doi: 10.1155/2022/1070697 66. Hasanova H, Tufail M, Baek UJ, Park JT, Kim MS. A novel blockchain-enabled heart disease prediction mechanism using machine learning. Comput Electr Eng. 2022;101:108086. 67. Kumar Y, Koul A, Singla R, Ijaz MF. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J Ambient Intell Hum Comput. 2022;13:1-28. 68. Tripoliti EE, Papadopoulos TG, Karanasiou GS, Naka KK, Fotiadis DI. Heart failure: diagnosis, severity estimation and prediction of adverse events through machine learning techniques. Comput Struct Biotechnol J. 2017;15:26-47. 69. Averbuch T, Sullivan K, Sauer A, Mamas MA, Voors AA, Gale CP, et al. Applications of artificial intelligence and machine learning in heart failure. European Heart J Digital Health. 2022;3(2):311-22. 70. Abdellatif AA, Mhaisen N, Chkirbene Z, Mohamed A, Erbad A, Guizani M. Reinforcement learning for intelligent healthcare systems: A comprehensive survey. 2021. arXiv:2108.04087
[Preprint]. 2021 Aug 5. Available from: https://arxiv.org/abs/2108.04087. Accessed 2023 Mar 30. 71. Yom-Tov E, Feraru G, Kozdoba M, Mannor S, Tennenholtz M, et al. Encouraging physical activity in patients with diabetes: intervention using a reinforcement learning system. J Med Internet Res. 2017;19(10):e338. 72. Zheng Q, Delingette H, Ayache N. Explainable cardiac pathology classification on cine MRI with motion characterization by semi-supervised learning of apparent flow. Med Image Anal. 2019;56:80-95. 73. Rao S, Li Y, Ramakrishnan R, Hassaine A, Canoy D, Cleland J, et al. An explainable Transformer-based deep learning model for the prediction of incident heart failure. IEEE J Biomed Health Inform. 2022;26(7):3362-72. 74. Kishor A, Jeberson W. Diagnosis of heart disease using internet of things and machine learning algorithms. In Proceedings of Second International Conference on Computing, Communications, and Cyber-Security. Singapore: Springer; 2021. pp. 691-702. 75. Jabeen F, Maqsood M, Ghazanfar MA, Aadil F, Khan S, Khan MF, et al. An IoT based efficient hybrid recommender system for cardiovascular disease. Peer-to-Peer Netw Appl. 2019;12:1263-76. doi: 10.1007/s12083-019-00733-3 76. Shang C, Chang CY, Liu J, Zhao S, Roy DS. FIID: Feature-based implicit irregularity detection using unsupervised learning from IoT data for homecare of elderly. IEEE Internet Things J. 2020;7(11):10884-96. doi:10.1109/jiot.2020.2990556 77. Liu Z, Yao C, Yu H, Wu T. Deep reinforcement learning with its application for lung cancer detection in medical Internet of Things. Future Gener Comput Syst. 2019;97:1-9. doi: 10.1016/j.future.2019.02.068 78. Sifat FH, Mahzabin R, Anjum S, Nayan AA, Kibria MG. IoT and Machine Learning-Based Hypoglycemia Detection System. In: 2022 International Conference on Innovations in Science, Engineering and Technology (ICISET). New York (US): IEEE; 2022. pp. 222-6. 79. Huang Y, Song I. PhysioVec: A Multi-stage Deep-Learning Framework for Searching Online Health Information with Breath Sound. In: 2022 IEEE 5th International Conference on Big Data and Artificial Intelligence (BDAI). New York (US): IEEE; 2022. pp. 26-33. 80. Lee C, Coughlin JF. PERSPECTIVE: Older adults' adoption of technology: an integrated approach to identifying determinants and barriers. J Prod Innov Manag. 2015;32(5):747-59. 81. Lakey SL, Gray SL, Borson S. Assessment of older adults' knowledge of and preferences for medication management tools and support systems. Ann Pharmacother. 2009;43(6):1011-9. 82. Dodd C, Athauda R, Adam M. Designing user interfaces for the elderly: a systematic literature review. In Australasian Conference on Information Systems; 2017 Dec 4-6; Hobart, Australia. Hobart (Australia): Australasian Conference on Information Systems; 2017. 83. Terry M. Medical identity theft and telemedicine security. Telemed e-Health. 2009;15(10):928-33. 84. Abdulmalek S, Nasir A, Jabbar WA, Almuhaya MA, Bairagi AK, Khan MA, et al. IoT-Based Healthcare-Monitoring System towards Improving Quality of Life: A Review. InHealthcare 2022;10(10):1993 85. Shah VN, DuBose SN, Li Z, Beck RW, Peters AL, Weinstock RS, et al. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. J Clin Endocrinol Metab. 2019;104(10):4356-64. doi: 10.1210/jc.2018-02763 86. Selvin E, Wang D, Tang O, Minotti M, Echouffo-Tcheugui JB, Coresh J. Glucose Patterns in Very Old Adults: A Pilot Study in a Community-Based Population. Diabetes Technol Ther. 2021;23(11):737-44. doi: 10.1089/dia.2021.0156 87. Kim YG, Moon JY, Oh B, Chin HJ, Kim DK, Park JH, et al. Pressure-Natriuresis Response Is Diminished in Old Age. Front Cardiovasc Med. 2022;9:840840. doi: 10.3389/fcvm.2022.840840 88. Poortvliet RK, Ford I, Lloyd SM, Sattar N, Mooijaart SP, de Craen AJ, et al. Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One. 2012;7(12):e52438. doi: 10.1371/journal.pone.0052438 89. Taillard J, Gronfier C, Bioulac S, Philip P, Sagaspe P. Sleep in Normal Aging, Homeostatic and Circadian Regulation and Vulnerability to Sleep Deprivation. Brain Sci. 2021;11(8):1003. doi: 10.3390/brainsci11081003 90. Jonasdottir SS, Minor K, Lehmann S. Gender differences in nighttime sleep patterns and variability across the adult lifespan: a global-scale wearables study. Sleep. 2021;44(2):zsaa169. doi: 10.1093/sleep/zsaa169 91. Alsalamah M, Alrehaili B, Almoamary A, Al-Juad A, Badri M, El-Metwally A. The optimal oral body temperature cutoff and other factors predictive of sepsis diagnosis in elderly patients. Ann Thorac Med. 2022;17(3):159-165. doi: 10.4103/atm.atm_52_22

引用本文

Brian F. Bender*,Jasmine A. Berry. Trends in Passive IoT Biomarker Monitoring and Machine Learning for Cardiovascular Disease Management in the U.S. Elderly Population, Advances in Geriatric Medicine and Research. 2023; 5; (1). https://doi.org/10.20900/agmr20230002.

文献评论

相关学者

相关机构